For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.

TNF is a cell signaling protein that plays a significant role in inflammatory bowel disease (IBS). Alon Levin investigates the mechanism of action of therapy that uses TNF inhibitors to treat IBS. The aim is to confirm the in vitro findings in vivo mouse models of IBS and to develop methods to enhance the therapeutic effect of anti-TNF.

Event details of Mechanism of anti-TNF therapy in inflammatory bowel disease
Date 19 January 2018
Time 11:00 -12:00
Location Aula - Lutherse kerk
Room Location

A.D. Levin: Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease. Towards improving Efficacy of Anti-TNF Therapy.

Supervisors

Prof. G.R. van den Brink

Prof. G.R.A.M. D'Haens

Co-supervisor

Dr M.E. Wildenberg

Aula - Lutherse kerk

Room Location

Singel 411
1012 XM Amsterdam

Entrance

This event is open to the public.